SEC 13F Intelligence

Dsam Partners (London) Ltd / RCKT

Dsam Partners (London) Ltd’s Rocket Pharmaceuticals Inc Position

Does Dsam Partners (London) Ltd own Rocket Pharmaceuticals Inc (RCKT)? Not currently — the last reported position was 140.3K shares worth $6M in Q2 2021; the fund’s latest 13F (Q3 2021) no longer reports it.

Position Value
$6M
Q2 2021
Shares
140.3K
% of Portfolio
+1.04%
Quarters Held
4
position exited

Position History RCKT

Reported value by quarter
Q3 ’20: $4MQ3 ’20Q4 ’20: $13MQ4 ’20Q1 ’21: $6MQ1 ’21Q2 ’21: $6MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021140.3K$6M+1.04%
Q1 2021140.3K$6M+1.15%
Q4 2020239.7K$13M+1.54%
Q3 2020179.6K$4M+0.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dsam Partners (London) Ltd’s full portfolio or all institutional holders of RCKT.